These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 20645431)

  • 21. Multilaboratory testing of thrombophilia: current and past practice in Australasia as assessed through the Royal College of Pathologists of Australasia Quality Assurance Program for Hematology.
    Favaloro EJ; Bonar R; Sioufi J; Wheeler M; Low J; Aboud M; Duncan E; Smith J; Exner T; Lloyd J; Marsden K;
    Semin Thromb Hemost; 2005 Feb; 31(1):49-58. PubMed ID: 15706475
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Study on usefulness of different APTT test kit in variable coagulopathy].
    Naito S; Ieko M; Yoshida M; Tarumi T; Nakabayashi T; Nishio H; Atsumi T
    Rinsho Byori; 2008 Mar; 56(3):195-202. PubMed ID: 18411803
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Prevalence of prolonged APTT and lupus anticoagulant in autoimmune thyroid disease].
    Tani Y; Morita M; Noguchi S
    Rinsho Byori; 1997 Sep; 45(9):899-902. PubMed ID: 9311265
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Lupus anticoagulant screening: comparison of 5 tests (author's transl)].
    Follea G; Ffrench P; Trzeciak MC; Dechavanne M
    Nouv Rev Fr Hematol (1978); 1981; 23(4):203-7. PubMed ID: 7312614
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of a standardized procedure with current laboratory practices for the detection of lupus anticoagulant in France. Working Group on Hemostasis of the Société Française de Biologie Clinique.
    Thromb Haemost; 1993 Nov; 70(5):781-6. PubMed ID: 8128435
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lupus anticoagulant syndrome: case report.
    Mwanda OW
    East Afr Med J; 1998 Oct; 75(10):619-20. PubMed ID: 10065201
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prolonged aPTT after kidney transplantation due to transient lupus anticoagulants.
    Nybo M; Dieperink H; Kristensen SR
    Nephrol Dial Transplant; 2006 Apr; 21(4):1060-5. PubMed ID: 16384821
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The activated seven lupus anticoagulant assay detects clinically significant antibodies.
    Moore GW; Rangarajan S; Savidge GF
    Clin Appl Thromb Hemost; 2008 Jul; 14(3):332-7. PubMed ID: 17895508
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic methodologies for circulating anticoagulants.
    Exner T
    Thromb Haemost; 1995 Jul; 74(1):338-44. PubMed ID: 8578481
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Routine Lupus Anticoagulant Sensitive aPTT Testing Can Prevent Unnecessary LA Testing.
    Smit B; Hudig F; Venhuizen JH; Haitjema S; Limper M; Urbanus R; Huisman A
    Clin Appl Thromb Hemost; 2023; 29():10760296231183427. PubMed ID: 37322895
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transient lupus anticoagulant associated with prothrombin deficiency: unusual cause of bleeding in a 5-year-old girl.
    Humphries JE; Acker MN; Pinkston JE; Ruddy S
    Am J Pediatr Hematol Oncol; 1994 Nov; 16(4):372-6. PubMed ID: 7978060
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of recently described tests for detection of the lupus anticoagulant.
    Forastiero RR; Cerrato GS; Carreras LO
    Thromb Haemost; 1994 Nov; 72(5):728-33. PubMed ID: 7900080
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recombinant thromboplastin inhibition assay for the detection of lupus anticoagulant.
    Zanon E; Saracino MA; Simioni P; Scarano L; Girolami B; Girolami A
    Clin Lab Haematol; 1995 Sep; 17(3):231-5. PubMed ID: 8719896
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Causes of isolated prolonged activated partial thromboplastin time in an acute care general hospital.
    Chng WJ; Sum C; Kuperan P
    Singapore Med J; 2005 Sep; 46(9):450-6. PubMed ID: 16123828
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lupus anticoagulants: diagnostic dilemma and clinical challenge.
    Triplett DA
    Clin Lab Sci; 1997; 10(4):223-8. PubMed ID: 10169622
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Similar mechanism of various lupus anticoagulants.
    Exner T
    Thromb Haemost; 1985 Feb; 53(1):15-8. PubMed ID: 3922078
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activated partial thromboplastin time reagents: an evaluation.
    Howarth S
    Br J Biomed Sci; 1993 Jun; 50(2):109-13. PubMed ID: 8219915
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Interference of factor VIII excess on the detection of lupus anticoagulants by the activated partial thromboplastin time].
    Guermazi S; Gorgi Y; Ayed K; Dellagi K
    Pathol Biol (Paris); 1997 Jan; 45(1):28-33. PubMed ID: 9097843
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alteration in the laboratory profile of a lupus anticoagulant in a patient with non-Hodgkin's lymphoma.
    Moore GW; Kamat AV; Gurney DA; O'Connor O; Rangarajan S; Carr R; Savidge GF
    Clin Lab Haematol; 2004 Dec; 26(6):429-34. PubMed ID: 15596003
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of the dilute Russell viper venom time (dRVVT): its importance and pitfalls.
    Triplett DA
    J Autoimmun; 2000 Sep; 15(2):173-8. PubMed ID: 10968905
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.